A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a randomized, double-blind, placebo-controlled trial designed to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of a single dose of the study drug or placebo administered subcutaneously to patients with moderate-to-severe chronic kidney disease and persistent inflammation.
Epistemonikos ID: 4ebb74469b12cab3b71f1d86d99d9e0866e7bf1e
First added on: May 20, 2024